CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: Results of the German Multicenter Trials for Adult ALL (GMALL)

Blood

Volumn 106, Issue 13, 2005, Pages 4054-4056

  Gleissner, Beate ^a   Goekbuget, Nicola ^b   Rieder, Harald ^b   Arnold, Renate ^b   Schwartz, Stefan ^b   Diedrich, Helmut ^b   Schoch, Claudia ^b   Heinze, Barbara ^b   Fonatsch, Christa ^b   Bartram, Claus R ^b   Hoelzer, Dieter ^b   Thiel, Eckhard ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL TRIAL; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE;

EID: 28844493138     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-05-1866     Document Type: Article

References (18)

1. Ludwig W-D, Rieder H, Bartram CR, et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukaemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood. 1998;92:1898-1909.
2. Charrin C, Magaud JP, Sebban D, et al. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A Collaborative Study of the Groupe Français de Cytogéné tique Hématologique. Blood. 1996;87:3135-3142.
3. Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM on behalf of the European 11q23 Workshop participants. The translocation, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. Leukemia. 1998;12:805-810.
4. Hayette S, Tigaud I, Maguer-Satta V, et al. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood. 2002;99:4647-4649.
5. Moorman AV, Richards S, Harrison C. Involvement of the MLL gene in T-lineage acute lymphoblastic leukemia. Blood. 2002;100:2273-2274.
6. Gleißner B, Gökbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood. 2002; 99:1356-1543.
7. Schwartz S, Rieder H, Schläger B, Burmeister T, Fischer L, Thiel E. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10/CD24/CD65s/CD15 B-cell phenotype. Leukemia. 2003;17:1589-1595.
8. Janssen JWG, Ludwig W-D, Borkhardt A, et al. Pre-Pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood. 1994;84:3835-3842.
9. Fonatsch C, Schaadt M, Kirchner HH, Diehl V. A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int J Cancer. 1980;26:749-756.
10. Mitelman F. ISCN:An International System of Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995.
11. ISCN Guidelines for Cancer Cytogenetics: Supplement to an International System for Human Cytogenetic Nomenclature, Karger, Basel, 1992.
12. Hoelzer D, Thiel E, Löffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukaemia in adults. Blood. 1988;71:123-131.
13. Goekbuget N, Hoelzer D, Arnold R, et al. Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am. 2000;14:1-19.
14. -)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood. 1989;73:1247-1258.
15. Pui C-H, Relling MV, Pharm D, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535-1548.
16. Bertrand FE, Vogtenhuber C, Shah N, LeBien TW. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein. Blood. 2001;98:3398-3405.
17. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30:41-47.
18. Rozovskaia T, Ravid-Amir O, Tillib S, et al. Expression profiles of acute lymphoblastic leukemia and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci U S A. 2003;100:7853-7858.